Biotech Firm Clears Major U.S. Trading Hurdle
Biotech Partnership to Revolutionize Diabetes Treatment
Biotech Enters Agreement with Co. Behind Tegoprubart
Research Report
AI Healthtech Firm Partners with EngageWell and CVS Health Foundation on NYC Senior Care Initiative
Biopharma Firm Assembles Elite AI Cancer Team
Canadian Biotech Targets Massive Cell Technology Gains
Research Report
Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion
Vaccine Co. Secures European Regulatory Breakthrough Potential
Research Report
GeoVax Labs Inc. (GOVX:NASDAQ) recently raised US$6 million, projected to find operations through the last quarter of 2025, according to a ROTH Capital Markets research note. The company also received highly favorable guidance for GEO-MVA, its prophylactic vaccine for Mpox and smallpox from The European Medicines Agency. Biotech Co. Still a Buy Despite Manufacturing Setbacks
Research Report
While it received a lower price target due to manufacturing setbacks, Jasper Therapeutics Inc. (JSPR:NASDAQ) is still a Buy, according to an H.C. Wainwright & Co. research note. Biotech Company Finds DNA-Targeting Drugs with AI in Canada
Biopharmaceutical company Rakovina Therapeutics Inc. (RKV:TSX.V) shared AGM results and key AI-driven cancer drug milestones in Vancouver. Read why some analysts are seeing a 300% potential returnAnalyst Has Confidence in Biotech's Path
Research Report
Vertex Pharmaceuticals Inc.'s (VRTX:NASDAQ) updated data is "a strong positive read-through for Sernova and help de-risk the broader field of cell-based therapies in T1D," according to an H.C. Wainwright & Co. research note. Isotope Co. Discovers Uranium-Helium Breakthrough Potential
ASP Isotopes Inc. (ASPI:NASDAQ) is seeing at least two major transformative developments this month. Read why one analyst sees these events as positive.Analyst Shares Thoughts After Microdisplay Co.'s Demo Day
Research Report
Kopin Corp.'s (KOPN:NASDAQ) display and optical technologies as well as its products are impressive, noted a Lake Street Capital Markets report. Sirens of High Finance
Contributed Opinion
Michael Ballanger of GGM Advisory Inc. shares his take on the current state of the market and reviews one copper stock he has been betting on for a while. Biotech Boasts Compelling Pipeline
Research Report
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) is exploring financing options with some potential sources of capital, noted a Research Capital Corp. report. California Biotech's Trial Shows Encouraging Results
Research Report
Kura Oncology Inc.'s (KURA:NASDAQ) KOMET-007 trial results, supporting ziftomenib's benefit-risk profile for first-line acute myeloid leukemia, were encouraging, according to an H.C. Wainwright & Co. research note. 
Streetwise Key Charts
